APA (7th ed.) Citation

SC, Y., SS, T., YL, C., YF, C., JC, L., CY, C., . . . BY, W. (2025). Efficacy and safety of cisplatin + docetaxel + 5-FU + leucovorin + methotrexate and epirubicin combination chemotherapy for advanced esophageal cancer. PloS one, 20(6), e0326056. https://doi.org/10.1371/journal.pone.0326056

Chicago Style (17th ed.) Citation

SC, Yu, Tong SS, Chen YL, Cheng YF, Lin JC, Cheng CY, Huang CL, Hu WH, and Wang BY. "Efficacy and Safety of Cisplatin + Docetaxel + 5-FU + Leucovorin + Methotrexate and Epirubicin Combination Chemotherapy for Advanced Esophageal Cancer." PloS One 20, no. 6 (2025): e0326056. https://doi.org/10.1371/journal.pone.0326056.

MLA (9th ed.) Citation

SC, Yu, et al. "Efficacy and Safety of Cisplatin + Docetaxel + 5-FU + Leucovorin + Methotrexate and Epirubicin Combination Chemotherapy for Advanced Esophageal Cancer." PloS One, vol. 20, no. 6, 2025, p. e0326056, https://doi.org/10.1371/journal.pone.0326056.